Although TLR2 is elevated in obese patients compared with healthy controls, it is unaltered in patients with limited liver disease compared with obesity-related NASH in two clinical studies [56, 57]. This evidence concerns the gene TLR2 and metabolic dysfunction-associated steatohepatitis.